Zika Virus Vaccines

The Live-Attenuated vaccine is developed to the disease caused by Zika Virus. The monovalent version of the vaccine is designed against Zika virus infection. Zika Virus belongs to the Genus Flavivirus, which is transmitted by the Aedes mosquitos.  The understanding of flavivirus particle structure, definition of E dimers as the key antigenic target, and deep understanding of neutralization mechanisms help to develop the vaccine.

  • Zika Virus Vaccine Development
  • Zika Virus Vaccines Recent Research
  • Zika Virus Vaccines Clinical Trials
  • Zika Virus Vaccine in Pregnant Women
  • Purified Inactivated Vaccine
  • DNA Vaccine
  • Live Attenuated Vaccine
  • DNA and mRNA Vaccine

Related Conference of Zika Virus Vaccines

October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan
December 06-07, 2018

International Congress on Vaccines & Immunology

Amsterdam, Netherlands
March 17-18, 2019

35th World Vaccines & Immunization Congress

Brisbane, Australia

Zika Virus Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in